Prognostic value of pre-operative systemic immune-inflammation index and platelet to lymphocyte ratio in peritoneal carcinomatosis of ovarian origin

Surg Oncol. 2022 Jun:42:101750. doi: 10.1016/j.suronc.2022.101750. Epub 2022 Mar 30.

Abstract

Background and objectives: The aim of this study was to investigate the impact of systemic immune-inflammation index (SII), platelet to lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR) on the survival outcomes of patients who underwent to cytoreductive surgery (CRS) and HIPEC for ovarian peritoneal carcinomatosis.

Methods: A retrospective analysis of 68 cases following surgery at our department between 2015 and 2020 was performed. Receiver Operating Characteristic (ROC) curve was used with Youden index to calculate the optimal cutoff values for SII, PLR and NLR.

Results: Univariate analysis revealed that high preoperative values of SII, PLR and NLR were correlated with worse overall survival (OS) and disease-free survival (DFS) in these patients. In the multivariable analysis, high SII was recognized as an independent prognostic factor for OS (CI 95%: 0.002- 3.835, p = 0.097) and high PLR was recognized as an independent prognostic factor for DFS (CI 95%: 0.253-2.248, p = 0.007).

Conclusion: SII and PLR could be useful prognostic tools to predict outcomes of patients who underwent to CRS and HIPEC for ovarian peritoneal carcinomatosis.

Keywords: Neutrophil to lymphocyte ratio; Ovarian cancer; Peritoneal carcinomatosis; Platelet to lymphocyte ratio; Prognosis; Systemic immune-inflammation index.

MeSH terms

  • Humans
  • Inflammation
  • Lymphocytes
  • Neutrophils
  • Peritoneal Neoplasms* / therapy
  • Prognosis
  • Retrospective Studies